Your browser doesn't support javascript.
loading
HyperTMO: a trusted multi-omics integration framework based on hypergraph convolutional network for patient classification.
Wang, Haohua; Lin, Kai; Zhang, Qiang; Shi, Jinlong; Song, Xinyu; Wu, Jue; Zhao, Chenghui; He, Kunlun.
Affiliation
  • Wang H; School of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.
  • Lin K; School of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.
  • Zhang Q; School of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.
  • Shi J; Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
  • Song X; Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
  • Wu J; Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
  • Zhao C; Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
  • He K; Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
Bioinformatics ; 40(4)2024 Mar 29.
Article in En | MEDLINE | ID: mdl-38530977
ABSTRACT
MOTIVATION The rapid development of high-throughput biomedical technologies can provide researchers with detailed multi-omics data. The multi-omics integrated analysis approach based on machine learning contributes a more comprehensive perspective to human disease research. However, there are still significant challenges in representing single-omics data and integrating multi-omics information.

RESULTS:

This article presents HyperTMO, a Trusted Multi-Omics integration framework based on Hypergraph convolutional network for patient classification. HyperTMO constructs hypergraph structures to represent the association between samples in single-omics data, then evidence extraction is performed by hypergraph convolutional network, and multi-omics information is integrated at an evidence level. Last, we experimentally demonstrate that HyperTMO outperforms other state-of-the-art methods in breast cancer subtype classification and Alzheimer's disease classification tasks using multi-omics data from TCGA (BRCA) and ROSMAP datasets. Importantly, HyperTMO is the first attempt to integrate hypergraph structure, evidence theory, and multi-omics integration for patient classification. Its accurate and robust properties bring great potential for applications in clinical diagnosis. AVAILABILITY AND IMPLEMENTATION HyperTMO and datasets are publicly available at https//github.com/ippousyuga/HyperTMO.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Alzheimer Disease Limits: Female / Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Alzheimer Disease Limits: Female / Humans Language: En Year: 2024 Type: Article